Abstract |
The aim of thrombolytic therapy after acute ischemic stroke is salvage of the ischemic penumbra. Several imaging techniques have been used to identify the penumbra in patients who may benefit from reperfusion beyond the currently narrow 3-hour time-window for thrombolysis. We discuss the advantages and disadvantages of positron emission tomography (PET), single photon emission computed tomography (SPECT), MRI and CT scans. We comment on concepts of clinical-imaging mismatch models and we explore the implications for clinical trials.
|
Authors | M Ebinger, D A De Silva, S Christensen, M W Parsons, R Markus, G A Donnan, S M Davis |
Journal | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
(J Clin Neurosci)
Vol. 16
Issue 2
Pg. 178-87
(Feb 2009)
ISSN: 0967-5868 [Print] Scotland |
PMID | 19097909
(Publication Type: Journal Article, Review)
|
Topics |
- Clinical Trials as Topic
- Diagnostic Imaging
(adverse effects, methods)
- Humans
- Reperfusion
(methods)
- Risk
- Stroke
(diagnosis)
|